Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales
12 Octobre 2023 - 2:05PM
Superlatus, Inc. (“Superlatus”), a food technology and
distribution company and wholly owned subsidiary of
TRxADE
HEALTH, Inc. (NASDAQ: MEDS, “TRxADE”), a pharmaceutical
exchange platform provider, is pleased to announce that its
subsidiary, Superlatus PD Holding Company, has entered into a
supplier agreement with Rainforest Distribution Corp.
(“Rainforest”), a leading Consumer Packaged Goods distributor
serving over 3,000 retailers across 15 states in the Mid-Atlantic,
Midwest, Northeast and North Atlantic regions of the United States.
Highlights of the New Distribution
Partnership:
- Superlatus has entered into a
strategic collaboration with Rainforest, a leading Direct Store
Delivery distributor serving the North Atlantic, Northeast,
Midwest, and Mid-Atlantic regions, specializing in better-for-you
brands. Superlatus and Rainforest will join forces to introduce
Superlatus' products to an extensive network of over 5,000 retail
locations, including prominent names such as Whole Foods, Kroger,
Moms Organics, ShopRite, Fairway, and more.
- With more than 50 sales
representatives, Rainforest is poised to support Superlatus's
diverse portfolio of Consumer Packaged Goods brands, such as
Coolhaus and Spero, among others.
- Rainforest's partnership will
provide Superlatus with a distribution ally, enabling increased
reach in the high-potential Tri-State area, home to over 33% of the
country's consumers. Their Direct Store Delivery model not only
expands the presence of Consumer Packaged Goods brands in major
retailers but also permeates the local businesses throughout New
York City.
- The collaboration with Rainforest
will provide revenue growth and expansion opportunities for
Superlatus's Consumer Package Goods portfolio, while establishing a
crucial presence in the largest market in the United States.
Superlatus CEO, Tim Alford, expressed his
enthusiasm about the supplier agreement with Rainforest,
emphasizing what this expanded distribution offers Superlatus. He
stated, "This partnership is a particularly significant milestone
for us as it unlocks the potential for substantial expansion across
North America, leveraging Rainforest's extensive distribution
network. We are genuinely thrilled to have the backing of this
top-tier wholesale distributor as we work towards a significant
ramp-up in our production."
About Rainforest Distribution
Rainforest Distribution Corp is a full-service
food and beverage distributor serving retailers in 16 states across
the Mid-Atlantic and Northeast regions of the United States.
Rainforest offers more than 5,000 high-velocity and on-trend SKUs
in ambient, refrigerated, and frozen formats. With distribution
centers in Maryland, New Jersey, and Massachusetts,
Rainforest offers customized distribution solutions designed to
ensure customer success in an increasingly competitive marketplace.
Rainforest's extensive sales and merchandising network adds value
through expertise in high-touch perishables, local & emerging
brands, custom retail programs, and the execution of
first-to-market concepts. For more information on Rainforest,
please visit Rainforest’s website
at www.rainforestdistribution.com.
About Superlatus, Inc.
Superlatus, Inc. is a diversified food
technology company with distribution capabilities. We scale food
innovation and transformational change to our food systems to
optimize food security and population health via innovative CPG
products, agritech, foodtech, plant-based proteins and
alt-proteins. We provide industry-leading processing and forming
technologies that create high nutrition, high taste, and textured
foods. Our management team consists of world-class food executives
with an unparalleled understanding of technology and taste. For
more information on Superlatus, please visit Superlatus’s website
at https://www.superlatusfoods.com.
About TRxADE HEALTH, INC.
TRxADE HEALTH, Inc. is a health services IT
company focused on digitalizing the retail pharmacy experience by
optimizing drug procurement, the prescription journey, and patient
engagement in the U.S. TRxADE plans to exit its legacy businesses
and focus on the Superlatus foods business after its next special
meeting of stockholders. For more information on TRxADE, please
visit the Company’s IR website
at investors.trxadegroup.com.
Forward-Looking Statements
Certain statements in this press release are
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934 and as that term is defined in the Private Securities
Litigation Reform Act of 1995. TRxADE intends that such
forward-looking statements be subject to the safe harbors created
thereby. Forward-looking statements relate to future events or
TRxADE’s future performance or future financial condition. These
forward-looking statements are not historical facts, but rather are
based on current expectations, estimates and projections about
TRxADE, its industry, beliefs, and assumptions. Such
forward-looking statements include, but are not limited to,
statements regarding TRxADE’s or TRxADE’s management team’s
expectations, hopes, beliefs, intentions or strategies regarding
the future, including TRxADE and Superlatus’ plans for and the
potential benefits of the supplier agreement and the products,
markets, and expected future performance and market opportunities
of TRxADE and Superlatus. In addition, any statements that refer to
projections, forecasts or other characterizations of future events
or circumstances, including any underlying assumptions, are
forward-looking statements. In some cases, you can identify
forward-looking statements by the following words: “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “intend,”
“may,” “ongoing,” “plan,” “potential,” “predict,” “project,”
“should,” or the negative of these terms or other similar
expressions, but the absence of these words does not mean that a
statement is not forward-looking. Forward-looking statements are
subject to a number of risks and uncertainties (some of which are
beyond TRxADE’s control) that may cause actual results or
performance to be materially different from those expressed or
implied by such forward-looking statements. Accordingly, readers
should not place undue reliance on any forward-looking statements.
These risks include risks relating to agreements with third
parties; TRxADE’s ability to raise funding in the future, as
needed, and the terms of such funding, including potential dilution
caused thereby; TRxADE’s ability to continue as a going concern;
security interests under certain of TRxADE’s credit arrangements;
TRxADE’s ability to maintain the listing of its common stock on The
Nasdaq Capital Market; claims relating to alleged violations of
intellectual property rights of others; the outcome of any current
legal proceedings or future legal proceedings that may be
instituted against TRxADE; unanticipated difficulties or
expenditures relating to TRxADE’s business plan; and those risks
detailed in TRxADE’s most recent Annual Report on Form 10-K and
subsequent reports filed with the Securities and Exchange
Commission. Forward-looking statements speak only as of the date
they are made. TRxADE undertakes no obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise that occur after that
date, except as otherwise provided by law.
Investor Contact:Skyline Corporate
Communications Group, LLCScott Powell, PresidentOne Rockefeller
Plaza, 11th FloorNew York, NY 10020Office: (646) 893-5835Email:
info@skylineccg.com
TRxADE Health (NASDAQ:MEDS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
TRxADE Health (NASDAQ:MEDS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024